The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Gonorrhea Diagnostics-Global Market Insights and Sales Trends 2024
Synopsis
Gonorrhea is a sexually transmitted disease caused by the bacterium Neisseria gonorrhoeae and can affect both genders. It is a common infection, especially among young people aged between 15 years to 24 years. According to the U.S. Centers for Disease Control and Prevention (CDC), gonorrhea is the second most commonly reported disease in the United States affecting approximately 800,000 people each year. In the United Kingdom, about 28,000 cases of gonorrhea are reported each year. Symptoms of gonorrhea in men encompass painful urination, swelling of testicles and pus discharge. In women, symptoms comprise excessive vaginal discharge, painful urination and abdominal pain. Complications include ectopic pregnancy, Pelvic Inflammatory Disease (PID) and Epididymitis. The incubation period for this disease also varies between men and women. In men, the symptoms occur between 2 to 14 days whereas in women it takes 7 days to 21 days to show symptoms. Astonishingly, about 50% of women have no symptoms in the early stage and during pregnancy it may infect the fetus during delivery.
The global Gonorrhea Diagnostics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Gonorrhea Diagnostics in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers, Diagnostic Centers and Clinics, are propelling Gonorrhea Diagnostics market. Chromatography, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diagnostic Imaging segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gonorrhea Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gonorrhea Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gonorrhea Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gonorrhea Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gonorrhea Diagnostics covered in this report include Abbott Laboratories, Beckman Coulter, Roche Diagnostics, Siemens, bioMérieux, PerkinElmer and Ortho Clinical Diagnostics, etc.
The global Gonorrhea Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Beckman Coulter
Roche Diagnostics
Siemens
bioMérieux
PerkinElmer
Ortho Clinical Diagnostics
Global Gonorrhea Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gonorrhea Diagnostics market, Segment by Type:
Chromatography
Diagnostic Imaging
Differential Light Scattering
Flow Cytometry
Gel Microdroplets
Immunoassay
Molecular Diagnostics
Monoclonal Antibodies Test
Global Gonorrhea Diagnostics market, by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Gonorrhea Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Gonorrhea is a sexually transmitted disease caused by the bacterium Neisseria gonorrhoeae and can affect both genders. It is a common infection, especially among young people aged between 15 years to 24 years. According to the U.S. Centers for Disease Control and Prevention (CDC), gonorrhea is the second most commonly reported disease in the United States affecting approximately 800,000 people each year. In the United Kingdom, about 28,000 cases of gonorrhea are reported each year. Symptoms of gonorrhea in men encompass painful urination, swelling of testicles and pus discharge. In women, symptoms comprise excessive vaginal discharge, painful urination and abdominal pain. Complications include ectopic pregnancy, Pelvic Inflammatory Disease (PID) and Epididymitis. The incubation period for this disease also varies between men and women. In men, the symptoms occur between 2 to 14 days whereas in women it takes 7 days to 21 days to show symptoms. Astonishingly, about 50% of women have no symptoms in the early stage and during pregnancy it may infect the fetus during delivery.
The global Gonorrhea Diagnostics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Gonorrhea Diagnostics in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers, Diagnostic Centers and Clinics, are propelling Gonorrhea Diagnostics market. Chromatography, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diagnostic Imaging segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gonorrhea Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gonorrhea Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gonorrhea Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gonorrhea Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gonorrhea Diagnostics covered in this report include Abbott Laboratories, Beckman Coulter, Roche Diagnostics, Siemens, bioMérieux, PerkinElmer and Ortho Clinical Diagnostics, etc.
The global Gonorrhea Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Beckman Coulter
Roche Diagnostics
Siemens
bioMérieux
PerkinElmer
Ortho Clinical Diagnostics
Global Gonorrhea Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gonorrhea Diagnostics market, Segment by Type:
Chromatography
Diagnostic Imaging
Differential Light Scattering
Flow Cytometry
Gel Microdroplets
Immunoassay
Molecular Diagnostics
Monoclonal Antibodies Test
Global Gonorrhea Diagnostics market, by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Gonorrhea Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Gonorrhea Diagnostics
1.1 Gonorrhea Diagnostics Market Overview
1.1.1 Gonorrhea Diagnostics Product Scope
1.1.2 Gonorrhea Diagnostics Market Status and Outlook
1.2 Global Gonorrhea Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Gonorrhea Diagnostics Market Size by Region (2018-2029)
1.4 Global Gonorrhea Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Gonorrhea Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Gonorrhea Diagnostics Market Size (2018-2029)
1.6.1 North America Gonorrhea Diagnostics Market Size (2018-2029)
1.6.2 Europe Gonorrhea Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Gonorrhea Diagnostics Market Size (2018-2029)
1.6.4 Latin America Gonorrhea Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Gonorrhea Diagnostics Market Size (2018-2029)
2 Gonorrhea Diagnostics Market by Type
2.1 Introduction
2.1.1 Chromatography
2.1.2 Diagnostic Imaging
2.1.3 Differential Light Scattering
2.1.4 Flow Cytometry
2.1.5 Gel Microdroplets
2.1.6 Immunoassay
2.1.7 Molecular Diagnostics
2.1.8 Monoclonal Antibodies Test
2.2 Global Gonorrhea Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Gonorrhea Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Gonorrhea Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Gonorrhea Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Gonorrhea Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Gonorrhea Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Gonorrhea Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Gonorrhea Diagnostics Revenue Breakdown by Type (2018-2029)
3 Gonorrhea Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Centers
3.1.3 Diagnostic Centers
3.1.4 Clinics
3.1.5 Others
3.2 Global Gonorrhea Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Gonorrhea Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Gonorrhea Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Gonorrhea Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Gonorrhea Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Gonorrhea Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Gonorrhea Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Gonorrhea Diagnostics Revenue Breakdown by Application (2018-2029)
4 Gonorrhea Diagnostics Competition Analysis by Players
4.1 Global Gonorrhea Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gonorrhea Diagnostics as of 2022)
4.3 Date of Key Players Enter into Gonorrhea Diagnostics Market
4.4 Global Top Players Gonorrhea Diagnostics Headquarters and Area Served
4.5 Key Players Gonorrhea Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Gonorrhea Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Gonorrhea Diagnostics Products, Services and Solutions
5.1.4 Abbott Laboratories Gonorrhea Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Beckman Coulter
5.2.1 Beckman Coulter Profile
5.2.2 Beckman Coulter Main Business
5.2.3 Beckman Coulter Gonorrhea Diagnostics Products, Services and Solutions
5.2.4 Beckman Coulter Gonorrhea Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Beckman Coulter Recent Developments
5.3 Roche Diagnostics
5.3.1 Roche Diagnostics Profile
5.3.2 Roche Diagnostics Main Business
5.3.3 Roche Diagnostics Gonorrhea Diagnostics Products, Services and Solutions
5.3.4 Roche Diagnostics Gonorrhea Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Siemens Recent Developments
5.4 Siemens
5.4.1 Siemens Profile
5.4.2 Siemens Main Business
5.4.3 Siemens Gonorrhea Diagnostics Products, Services and Solutions
5.4.4 Siemens Gonorrhea Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Siemens Recent Developments
5.5 bioMérieux
5.5.1 bioMérieux Profile
5.5.2 bioMérieux Main Business
5.5.3 bioMérieux Gonorrhea Diagnostics Products, Services and Solutions
5.5.4 bioMérieux Gonorrhea Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 bioMérieux Recent Developments
5.6 PerkinElmer
5.6.1 PerkinElmer Profile
5.6.2 PerkinElmer Main Business
5.6.3 PerkinElmer Gonorrhea Diagnostics Products, Services and Solutions
5.6.4 PerkinElmer Gonorrhea Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 PerkinElmer Recent Developments
5.7 Ortho Clinical Diagnostics
5.7.1 Ortho Clinical Diagnostics Profile
5.7.2 Ortho Clinical Diagnostics Main Business
5.7.3 Ortho Clinical Diagnostics Gonorrhea Diagnostics Products, Services and Solutions
5.7.4 Ortho Clinical Diagnostics Gonorrhea Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Ortho Clinical Diagnostics Recent Developments
6 North America
6.1 North America Gonorrhea Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Gonorrhea Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Gonorrhea Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Gonorrhea Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Gonorrhea Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Gonorrhea Diagnostics Market Dynamics
11.1 Gonorrhea Diagnostics Industry Trends
11.2 Gonorrhea Diagnostics Market Drivers
11.3 Gonorrhea Diagnostics Market Challenges
11.4 Gonorrhea Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
